Sameer Jain

November 30, 2020 | Published by

COVID-19 impact on Pharma sector.
“COVID-19 is expected to lay the foundation of a ‘new normal’ by accelerating cycle times across the Pharma value chain”, says Sameer. This would not only greatly help fighting future pandemics like COVID-19 but also enable the faster release of medicines for other critical ailments/diseases and possibly at a lower cost as well.

Read more